“…Seven studies examined ketorolac at various doses as an opioid-sparing strategy, and results from these studies are summarized in Table 2. 13,16,21,25,31,39,40 Each study evaluated ketorolac treatment against a control group that did not receive the NSAID, and all of these studies reported significant opioid-sparing effects with ketorolac. Opioidsparing effects were determined versus a background of PCA opioids in 6 of the 7 studies, 13,21,25,31,39,40 and versus morphine titrated to pain level as rescue medication in the remaining study.…”